Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR

Top Cited Papers
Open Access
Abstract
The success of the CRISPR/Cas9 genome editing technique depends on the choice of the guide RNA sequence, which is facilitated by various websites. Despite the importance and popularity of these algorithms, it is unclear to which extent their predictions are in agreement with actual measurements. We conduct the first independent evaluation of CRISPR/Cas9 predictions. To this end, we collect data from eight SpCas9 off-target studies and compare them with the sites predicted by popular algorithms. We identify problems in one implementation but found that sequence-based off-target predictions are very reliable, identifying most off-targets with mutation rates superior to 0.1 %, while the number of false positives can be largely reduced with a cutoff on the off-target score. We also evaluate on-target efficiency prediction algorithms against available datasets. The correlation between the predictions and the guide activity varied considerably, especially for zebrafish. Together with novel data from our labs, we find that the optimal on-target efficiency prediction model strongly depends on whether the guide RNA is expressed from a U6 promoter or transcribed in vitro. We further demonstrate that the best predictions can significantly reduce the time spent on guide screening. To make these guidelines easily accessible to anyone planning a CRISPR genome editing experiment, we built a new website ( http://crispor.org ) that predicts off-targets and helps select and clone efficient guide sequences for more than 120 genomes using different Cas9 proteins and the eight efficiency scoring systems evaluated here.
Funding Information
  • National Human Genome Research Institute (5U41HG002371-15)
  • National Cancer Institute (NIH/NCI 5U54HG007990-02)
  • California Institute for Regenerative Medicine (CIRM GC1R-06673C)
  • Agence Nationale de la Recherche (ANR-II-INBS-0014)
  • Agence Nationale de la Recherche (CILIAINTHEBRAIN)
  • Fondation pour la Recherche Médicale (FRM DEQ20140329544)